Back

A multifactorial porcine model of cardio-metabolic HFpEF highlights miR-483-3p as a promising target therapy

30 August 2026 (10:15 - 11:00)
Organised by: Logo
Congress Presentation Part of: Heart failure: back to basics Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Katharina Wierling

German Heart Center Of Charite Berlin (Germany)

5 More presentations in this session

Presentation thumbnail
Left atrioventricular coupling index predicts prognosis and pulmonary vascular dysfunction in heart failure with preserved ejection fraction
Ms E. Hasegawa (Toyonaka, JP)
Abstract Slides
Presentation thumbnail
PTFV1 is associated with functional atrial myopathy and atrial inflammation in HFpEF patients undergoing CABG
Ms R. Hultsch (Regensburg, DE)
Abstract Slides Video
Presentation thumbnail
Left atrial mechanics and ventilatory performance in HFpEF patients evaluated with simultaneous cardiopulmonary exercise test and stress echocardiography
Doctor M. Losito (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Аtrial cardiomyopathy as a determinant of stroke risk in heart failure with preserved ejection fraction and non-permanent atrial fibrillation
Associate Professor L. Hazarapetyan (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
NRAP marks adaptive premyofibril-like structures during pathological cardiac remodeling
Doctor T. Yang (Beijing, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Heart failure: back to basics

The Event

Event poster

ESC Congress 2026

30 August 2026 10:15 CET
You may be interested in
thumbnail
Congress Presentation
Pressure overload and volume overload-induced chronic heart failure are associated with unique myocardial microRNA expression patterns
29 June 2021
thumbnail
Congress Presentation
Coronary microvascular dysfunction, central and overall obesity and metabolic and fibrotic biomarkers in patients with heart failure with preserved ejection fraction (data from PROMIS-HFpEF)
21 May 2023
thumbnail
Congress Presentation
A multifactorial porcine model of cardio-metabolic HFpEF highlights miR-483-3p as a promising target therapy
17 May 2025
thumbnail
Congress Presentation
New advanced heart failure (HF) pig model with reduced ejection fraction and clinically relevant cardiopulmonary congestion.
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources